Ovarian cancer: imaging in treatment selection and planning with FIGO update

Oral presentation

.... FIGO has recently revised the staging of ovarian cancer [1]. It includes a revision of the stage III patients and allotment to stage IIIA1 is based on spread to the retroperitoneal lymph nodes without intraperitoneal dis-semination, because an analysis of these patients indicates that their survival is significantly better than those who have intraperitoneal dissemination [1]...